Fulgent Genetics, Inc. has made a significant move by entering into a lease agreement for a new facility in Needham, Massachusetts. This lease is expected to enhance the company's operational capacity for office, research and development, diagnostic laboratory services, and light manufacturing. The decision to expand comes at a time when the medical laboratory industry is experiencing increased demand for diagnostic services.

On November 16, 2026, Fulgent signed the lease with EP 63 Kendrick Realty LLC for approximately 44,644 rentable square feet. The facility will serve multiple functions, including an anatomic pathology laboratory and warehouse space. The lease term is set to begin on the earlier of August 1, 2027, or when a final Certificate of Use and Occupancy is issued.

The initial monthly base rent is $132,071.83, with annual increases of 3.0%. Notably, the lease includes options for two successive five-year extensions at fair market rent, allowing Fulgent to adapt to future growth needs. Additionally, the landlord will provide a tenant improvement allowance of up to $100 per rentable square foot, further supporting the company's investment in the new space.

Fulgent's move to secure this facility reflects its commitment to expanding its capabilities in the competitive medical laboratory sector. The company is also making a cash security deposit of $792,431, which may be reduced under certain conditions. This strategic decision is likely to impact not only Fulgent but also its competitors in the medical laboratory services industry.

As the lease progresses, Fulgent will be responsible for interior repairs, replacements, and its share of operating costs. The lease agreement also includes provisions for rent abatement and termination rights should the landlord fail to deliver the premises by specified dates.

Details regarding the lease will be further elaborated in Fulgent's upcoming Annual Report on Form 10-K for the fiscal year ending December 31, 2026. The filing does not specify what happens next, but the new facility is anticipated to play a crucial role in Fulgent's operational strategy moving forward.